Lab Results

What Causes HDL to Be Out of Range?: A Functional-Medicine Interpretation Guide

HDL cholesterol is often dismissed as simply 'the good kind,' but both low and high readings carry meaningful clinical risk. Functional medicine looks beyond the standard reference range to understand what's actually driving your HDL number — and the answer is rarely just diet.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
HDL cholesterolcardiovascular biomarkersfunctional medicinelipid panelmetabolic healththyroid and cholesterol
What Causes HDL to Be Out of Range?: A Functional-Medicine Interpretation Guide

What Causes HDL to Be Out of Range?: A Functional-Medicine Interpretation Guide

HDL cholesterol gets a lot of praise as the "good" cholesterol, but that shorthand obscures a more complex reality. When your HDL is out of range — whether too low or, surprisingly, too high — it signals something deeper about your metabolic, inflammatory, and hormonal health. A functional-medicine interpretation doesn't stop at the number; it asks why that number exists and what systems are under stress.

This guide walks through what causes HDL to be out of range, how to interpret your result against both conventional and functional thresholds, and what that reading may reveal about interconnected biomarkers including fibrinogen — a cardiovascular inflammation marker that frequently moves in tandem with HDL.

---

Understanding HDL: Reference Ranges vs. Optimal Ranges

Conventional lab reference ranges for HDL are set to identify the lowest-risk population percentile, not to define optimal health. Here's how standard and functional targets compare:

MarkerConventional Reference RangeFunctional Optimal Range
HDL (men)≥ 40 mg/dL55–80 mg/dL
HDL (women)≥ 50 mg/dL65–90 mg/dL
HDL (both)> 60 mg/dL considered protective> 60 mg/dL, but > 100 mg/dL may indicate dysfunction

The American Heart Association and National Cholesterol Education Program have long used 40 mg/dL (men) and 50 mg/dL (women) as minimum thresholds, but landmark data from the Framingham Heart Study and EPIC-Norfolk cohort suggest that the quality of HDL particles matters as much as the quantity (Khera et al., New England Journal of Medicine 2011; PMID: 21992124).

What Low HDL Actually Means

Low HDL (below 40 mg/dL in men, below 50 mg/dL in women) is one of the five diagnostic criteria for metabolic syndrome. But from a functional standpoint, a low HDL is a downstream symptom, not a standalone problem. Common root causes include:

  • Insulin resistance and hyperinsulinemia: Elevated insulin suppresses the enzyme lipoprotein lipase and accelerates HDL catabolism. Studies in large epidemiological cohorts consistently show an inverse relationship between fasting insulin and HDL-C levels (Laakso et al., Arteriosclerosis, Thrombosis, and Vascular Biology 1993; PMID: 8220352).
  • Chronic low-grade inflammation: Pro-inflammatory cytokines such as IL-6 and TNF-α reduce the expression of apolipoprotein A-I (ApoA-I), the primary structural protein of HDL. When systemic inflammation is high, the liver produces less ApoA-I, and HDL production falls accordingly.
  • Sedentary lifestyle: Physical inactivity is one of the most modifiable causes of low HDL. Aerobic exercise reliably increases HDL by 5–10% through upregulation of hepatic lipase and lecithin-cholesterol acyltransferase (LCAT) activity (Kodama et al., Archives of Internal Medicine 2007; PMID: 17420424).
  • Dietary fat quality: Diets high in trans-fatty acids and refined carbohydrates suppress HDL, while replacing carbohydrates with monounsaturated and omega-3 fatty acids raises HDL (Mensink et al., American Journal of Clinical Nutrition 2003; PMID: 12716665).
  • Smoking: Cigarette smoking reduces HDL by approximately 4–6 mg/dL through oxidative stress mechanisms that degrade ApoA-I.
  • Hypothyroidism: Thyroid hormones regulate the expression of hepatic lipase and scavenger receptor BI (SR-BI), both critical for HDL metabolism. Low thyroid function is a frequently overlooked cause of a dyslipidemia panel that shows both low HDL and elevated LDL.
  • Certain medications: Beta-blockers, anabolic steroids, and progestins can all lower HDL.

What High HDL May Signal

For years, high HDL was assumed to be universally protective. Recent Mendelian randomization studies have challenged this. Extremely high HDL (above 90–100 mg/dL) may indicate dysfunctional HDL particles that are not performing reverse cholesterol transport efficiently. Genetic variants such as CETP mutations can elevate HDL mass while actually impairing its function (Voight et al., The Lancet 2012; PMID: 22607825).

High HDL can also reflect:

  • Heavy alcohol consumption (alcohol transiently raises HDL but through a non-atheroprotective mechanism)
  • Certain autoimmune states
  • CETP inhibition (a pharmacological effect that raised HDL but did not reduce cardiovascular events in large trials)

---

What Causes Fibrinogen to Be Out of Range? (And Why It Matters for HDL)

Fibrinogen is a plasma protein produced by the liver that plays a central role in blood clotting and wound healing. Its connection to HDL is clinically important: when fibrinogen is elevated, HDL is almost always suppressed — because both biomarkers are driven by the same inflammatory upstream signals.

Reference range: 200–400 mg/dL (conventional); functional practitioners often prefer 180–350 mg/dL.

What raises fibrinogen?

  • Systemic inflammation (elevated CRP, IL-6)
  • Metabolic syndrome
  • Obesity — adipose tissue is a primary source of pro-inflammatory cytokines that stimulate hepatic fibrinogen synthesis
  • Smoking
  • Estrogen dominance or oral contraceptive use
  • Chronic infections (periodontitis, H. pylori)
  • Hypothyroidism

What lowers fibrinogen?

  • Omega-3 fatty acids (EPA/DHA at doses of 2–4g/day have been shown to reduce fibrinogen by 10–16% in inflammatory states)
  • Regular aerobic exercise
  • Nattokinase supplementation
  • Dietary approaches that reduce overall inflammatory burden

The functional take: if your fibrinogen is elevated and your HDL is low, you're looking at a systemic inflammatory profile — not an isolated lipid problem. Addressing the root of the inflammation will move both biomarkers simultaneously. Learning more about interpreting cardiovascular biomarkers together can help you see these patterns clearly.

---

The Thyroid-HDL Connection: TSH, Free T3, and Free T4

Thyroid function and lipid metabolism are tightly coupled. This is why a comprehensive cardiometabolic workup should always include thyroid markers — and why a low HDL reading often warrants a closer look at thyroid status.

TSH Out of Range and Lipid Implications

TSH (thyroid-stimulating hormone) is the pituitary's signal to the thyroid to produce hormones. When TSH is elevated, it indicates the thyroid is underperforming. Even subclinical hypothyroidism — TSH between 2.5 and 4.5 mIU/L with normal T4 — has been associated with atherogenic lipid profiles including reduced HDL and elevated LDL and triglycerides (Canaris et al., Archives of Internal Medicine 2000; PMID: 10695693).

Functional-medicine practitioners typically prefer TSH in the range of 1.0–2.0 mIU/L. A TSH sitting at 3.8 mIU/L is technically "normal" by conventional labs but may be contributing to a lipid panel that looks progressively worse year over year.

Free T4 Out of Range

Free T4 (thyroxine) is the storage form of thyroid hormone. When free T4 is low-normal or below range, it suggests the thyroid gland itself isn't producing adequate hormone — regardless of what TSH shows. Low free T4 reduces hepatic LDL receptor activity and impairs the liver's ability to clear atherogenic particles, contributing to the dyslipidemia pattern that accompanies hypothyroidism.

Conventional range: 0.8–1.8 ng/dL. Functional optimal: 1.1–1.6 ng/dL.

Free T3 Out of Range

Free T3 (triiodothyronine) is the metabolically active form of thyroid hormone. Even if TSH and T4 look acceptable, poor conversion of T4 to T3 — often driven by chronic inflammation, selenium deficiency, or high cortisol — can leave cells functionally hypothyroid. T3 directly regulates the expression of SR-BI receptors in the liver, which govern HDL uptake and recycling. Low free T3 translates to impaired HDL metabolism at the cellular level.

Conventional range: 2.3–4.2 pg/mL. Functional optimal: 3.2–4.0 pg/mL.

If your HDL is low and your free T3 is sitting at 2.5 pg/mL, that's a meaningful connection most standard lipid panels miss entirely. For a deeper look at how thyroid health affects your entire metabolic panel, the picture becomes even clearer.

---

Lifestyle and Nutritional Root Causes: A Prioritized Overview

Before reaching for any intervention, it helps to rank the modifiable contributors to low HDL by effect size:

  1. Correct insulin resistance — fasting insulin testing (not just fasting glucose) reveals early metabolic dysfunction. Reducing refined carbohydrate intake and intermittent caloric restriction consistently raise HDL in insulin-resistant individuals.
  2. Increase aerobic activity — 150+ minutes per week of moderate-intensity exercise is the most consistently effective lifestyle intervention for raising HDL (Kodama et al., 2007; PMID: 17420424).
  3. Optimize dietary fat quality — increasing omega-3 intake and replacing refined carbohydrates with monounsaturated fats (olive oil, avocado) raises HDL and shifts LDL toward larger, less atherogenic particle sizes (Mensink et al., 2003; PMID: 12716665).
  4. Reduce alcohol intake — moderate drinking transiently raises HDL, but regular heavy drinking causes liver inflammation that ultimately suppresses HDL function.
  5. Quit smoking — smoking cessation raises HDL by 4–6 mg/dL within months.
  6. Optimize thyroid function — address TSH, free T3, and free T4 if thyroid markers are suboptimal.
  7. Reduce systemic inflammation — track hs-CRP, fibrinogen, and homocysteine as proxy markers for the inflammatory burden dragging down HDL.

---

What This Means for Your Formula

When Ones analyzes your lab data, a low HDL reading doesn't trigger a one-size-fits-all response. The AI looks at HDL alongside your TSH, fibrinogen, fasting glucose, triglycerides, and inflammatory markers to understand the pattern — and then builds a formula targeting the most upstream drivers.

Omega-3 (EPA/DHA): EPA and DHA at therapeutic doses reduce triglycerides (which are inversely related to HDL), lower fibrinogen, and decrease the systemic inflammatory cytokines that suppress ApoA-I production. The REDUCE-IT trial demonstrated that 4g/day of EPA reduced major cardiovascular events by 25% in high-risk patients, and community-level data consistently show HDL-supportive effects at 2–4g daily doses. Ones includes pharmaceutical-grade Omega-3 calibrated to your triglyceride and inflammatory load.

Ones Liver Support blend: The liver is the primary site of HDL synthesis and recycling. Compromised liver function — even subclinical, detected through elevated ALT/AST or low albumin — undermines HDL production. Ones' proprietary Liver Support blend contains ingredients that support hepatic detoxification pathways and bile acid metabolism, both of which influence lipid handling.

Ones Heart Support blend: When HDL is low and fibrinogen or hs-CRP is elevated, Ones' Heart Support system blend addresses the cardiovascular inflammatory environment directly, combining ingredients that support endothelial function and vascular tone. This isn't about masking a number — it's about restoring the environment in which HDL can function properly.

For users whose low HDL traces back to thyroid dysfunction (identifiable through free T3, free T4, and TSH patterns), the AI may also recommend ingredients that support T4-to-T3 conversion, recognizing that no HDL intervention works optimally in an unaddressed thyroid environment. Explore more about how personalized supplement formulas are built from lab data for context on this approach.

---

Key Takeaways

  • HDL below 40 mg/dL (men) or 50 mg/dL (women) meets one criterion for metabolic syndrome, but functional-medicine targets are 10–20 mg/dL higher than conventional minimums.
  • Low HDL is rarely isolated: insulin resistance, chronic inflammation, hypothyroidism, smoking, and poor dietary fat quality are the most common root causes — and they interact.
  • Extremely high HDL (>100 mg/dL) may reflect dysfunctional particles or genetic variants (e.g., CETP mutations) and is not necessarily protective.
  • Fibrinogen and HDL move together: elevated fibrinogen alongside low HDL is a systemic inflammatory signal, not two separate problems.
  • Thyroid markers matter: low free T3 directly impairs HDL metabolism at the hepatic receptor level; TSH above 2.5 mIU/L warrants investigation when HDL is trending down.
  • The most effective HDL interventions — in order of evidence strength — are aerobic exercise, dietary fat quality improvement, insulin resistance correction, and targeted supplementation guided by the full lab picture.

Always consult a qualified healthcare provider before making changes to your supplement regimen or interpreting lab results for medical decision-making.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Related reading